Diagnostics & biomarkers

Colon Cancer Immunotherapy Moves Into the Adjuvant Access Test

Personalised cardiology cannot succeed if women’s hearts still follow men’s pathways

Alzheimer’s Research Moves Beyond Amyloid

Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up

AML’s Frontline Future Starts With Finding the Mutation Fast

Cellular Reprogramming Enters Neuro-Ophthalmology

Chronic pain may be a cardiovascular warning sign, not just a symptom

AML’s Frontline Future Starts With Finding the Mutation Fast

FSHD Gets a Stronger Biological Signal
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
